Skip to main content

Want a detailed portfolio tracker?

Biodesix (BDSX) P/E (2020 - 2026)

Biodesix (BDSX) P/E from Oct 28, 2020 to Jul 21, 2026. The TTM Biodesix (BDSX) P/E is -5.40. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Biodesix (BDSX)

YearP/EChange
2026-5.40+270.07%
2025-1.46-67.40%
2024-4.48+93.61%
2023-2.31+65.72%
2022-1.40-59.38%
2021-3.43-27.39%
2020-4.73N/A

Comparison Biodesix (BDSX) P/E with competitors

Biodesix (BDSX) P/E is -5.40.

TickerNameP/EUpside
ADVBAdvanced Biomed Inc1.05-119.41%
MBAICheckCap Ltd1.71-131.71%
FONRFonar Corp15.48-386.59%
QGENQiagen NV20.03-470.86%
DGXQuest Diagnostics Inc22.47-516.10%
LHLaboratory Corp Of America Holdings23.87-541.98%
IQVIQVIA Holdings Inc25.28-568.12%
AAgilent Technologies Inc26.96-599.14%
TMOThermo Fisher Scientific Inc31.53-683.77%
MTDMettler-Toledo International Inc32.45-700.83%
MEDPMedpace Holdings Inc32.55-702.67%
DHRDanaher Corp38.55-813.83%
IDXXIdexx Laboratories Inc40.58-851.27%
ILMNIllumina Inc44.12-916.89%
RVTYRevvity Inc52.68-1075.41%
VCYTVeracyte Inc53.71-1094.50%
ICLRIcon Plc57.45-1163.73%
SHCSotera Health Company74.08-1471.70%
WATWaters Corp102.79-2003.12%